Austin, TX -- (SBWIRE) -- 05/08/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-
Research In Motion Ltd(NASDAQ:BBRY) shares decreased 4.81% to $14.82. The company on May 1 announced appointment of Sunil Lalvani as the new managing director for its operations in India. The top management shuffling comes just months after the company launched it’s latest touch based and keyboard holder smartphone BlackBerry Z10.
Additionally, the company, on April 10, reported that a number of retailers and wireless carriers in Canada have started taking pre-orders for Research In Motion Ltd (NASDAQ:BBRY)’s brand new Q10 smartphone featuring a QWERTY keyboard.
Can BBRY Recover after the Recent fall? Find Out Here
Arch Coal Inc (NYSE:ACI) shares fell 4.80% to $4.96. The company on April 23 reported a first-quarter loss on lower production and prices.
The company posted a loss of $70 million, or 33 cents per share, for the quarter that ended March 31. That compares with earnings of $1.2 million, or 1 cent per share, in the same quarter last year. Excluding one-time items, the loss was 34 cents per share. Revenue fell to $825.5 million from $1.04 billion. Analysts expected a loss of 33 cents per share on revenue of $914.2 million.
Additionally, ACI’s stock was upgraded by research analysts at Goldman Sachs from a "sell" rating to a "neutral" rating in a report released on May 7.
Can ACI Continue To Move Higher? Find Out Here
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares decreased 4.93% to $12.15. The company CLDX) released its earnings data on May 2. The company reported ($0.23) earnings per share for the quarter, missing the analysts' consensus estimate of ($0.22) by $0.01. The company had revenue of $2.41 million for the quarter, compared to the consensus estimate of $2.65 million.
Additionally, the company announced that Tibor Keler, Ph.D., Senior Vice President and Chief Scientific Officer, will present an overview of the Company's antibody technology and pipeline at the Credit Suisse Antibody Day on Friday, May 10, 2013 at 11:00 am ET in New York.
How Should Investors Trade CLDX Now? Find Out Here
Jackpotpennystocks.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Jackpotpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Jackpotpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)